Across TCGA pan-cancer cohorts, PDCL3P1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of PDCL3P1’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where PDCL3P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PDCL3P1 is over-expressed in tumor.

BRCA and LUAD are the cancer types where PDCL3P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PDCL3P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.053	.010	4	view →
LUAD	All	All	+0.032	.012	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: PDCL3P1 RNA expression & survival · all PDCL3P1 data types